In anaplastic thyroid carcinoma, two ALK point mutations, C3592T and G3602A, were identified in the tyrosine kinase domain, promoting cell proliferation and invasion by activating signaling pathways (20). The gene discussed is ALK; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.